These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Values of Body Mass Index and Chest CT Features in the Assessment of Chronic Obstructive Pulmonary Disease]. Li L, Liu Y, Li J, Gao JM. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb 28; 42(1):55-61. PubMed ID: 32131940 [Abstract] [Full Text] [Related]
4. Structural features on quantitative chest computed tomography of patients with maximal mid-expiratory flow impairment in a normal lung function population. Yang Y, Ge H, Lu J, Huang X, Wang K, Jin L, Qi L, Li M. BMC Pulm Med; 2023 Mar 15; 23(1):86. PubMed ID: 36922831 [Abstract] [Full Text] [Related]
5. Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease. Yasui H, Inui N, Karayama M, Mori K, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T. Respir Med; 2019 Jan 15; 146():76-80. PubMed ID: 30665522 [Abstract] [Full Text] [Related]
6. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study. Zhang J, Lin XF, Bai CX. Int J Chron Obstruct Pulmon Dis; 2014 Jan 15; 9():57-63. PubMed ID: 24426780 [Abstract] [Full Text] [Related]
7. Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease. Nambu A, Zach J, Schroeder J, Jin G, Kim SS, Kim YI, Schnell C, Bowler R, Lynch DA. Eur J Radiol; 2016 Nov 15; 85(11):2144-2151. PubMed ID: 27776670 [Abstract] [Full Text] [Related]
9. Subtyping preserved ratio impaired spirometry (PRISm) by using quantitative HRCT imaging characteristics. Lu J, Ge H, Qi L, Zhang S, Yang Y, Huang X, Li M. Respir Res; 2022 Nov 11; 23(1):309. PubMed ID: 36369019 [Abstract] [Full Text] [Related]
10. The effect of comorbidities on COPD assessment: a pilot study. Weinreich UM, Thomsen LP, Bielaska B, Jensen VH, Vuust M, Rees SE. Int J Chron Obstruct Pulmon Dis; 2015 Nov 11; 10():429-38. PubMed ID: 25750525 [Abstract] [Full Text] [Related]
11. Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study. Huang WC, Wu MF, Chen HC, Hsu JY, TOLD Group. NPJ Prim Care Respir Med; 2015 Nov 05; 25():15063. PubMed ID: 26538368 [Abstract] [Full Text] [Related]
12. Role of the Emphysema Index Combined with the Chronic Obstructive Pulmonary Disease Assessment Test Score in the Evaluation of Chronic Obstructive Pulmonary Disease. Ding Q, Wei X, Li J, Gao YZ, Xu SD, Yu N, Mi JY, Mi BB, Guo YM. Can Respir J; 2021 Nov 05; 2021():9996305. PubMed ID: 34691315 [Abstract] [Full Text] [Related]
13. Sex-related differences in bronchial parameters and pulmonary function test results in patients with chronic obstructive pulmonary disease based on three-dimensional quantitative computed tomography. Li Y, Dai YL, Yu N, Guo YM. J Int Med Res; 2018 Jan 05; 46(1):135-142. PubMed ID: 28758847 [Abstract] [Full Text] [Related]
18. Three-dimensional airway lumen volumetry: comparison with bronchial wall area and parenchymal densitometry in assessment of airway obstruction in pulmonary emphysema. Koyama H, Ohno Y, Nishio M, Takenaka D, Yoshikawa T, Matsumoto S, Nishimura Y, Sugimura K. Br J Radiol; 2012 Dec 05; 85(1020):1525-32. PubMed ID: 22932062 [Abstract] [Full Text] [Related]